BioSpace News Archive

Biotech Bay

180 Life Sciences to Participate in A.G.P.’s Virtual Biotech Conference to be Held November 30 – December 1, 2022

180 Life Sciences Corp. today announced that the Company will participate in A.G.P.’s Virtual Biotech Conference to be held November 30 – December 1, 2022.

November 21, 2022
·
7 min read
Pharm Country

Schrödinger to Present at Piper Sandler 34th Annual Healthcare Conference

Schrödinger today announced that management will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference.

November 21, 2022
·
1 min read
Lone Star Bio

New Published Study Further Demonstrates the Ability of Natera’s mPCR Technology to Monitor Immunotherapy Response in Metastatic Uveal Melanoma Patients

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the publication of a new study in Nature Medicine, which shows that its mPCR technology is able to assess response to tebentafusp in treatment-refractory metastatic uveal melanoma.

November 21, 2022
·
3 min read
Pharm Country

Legend Biotech Announces FDA Clearance of IND Application for LB2102 in Extensive Stage Small Cell Lung Cancer

Legend Biotech Corporation announced today that the U.S. Food and Drug Administration (FDA) has cleared Legend Biotech’s Investigational New Drug (IND) application to proceed with the clinical development of LB2102.

November 21, 2022
·
6 min read
Genmab Announces U.S. Food and Drug Administration Accepts for Priority Review Biologics License Application (BLA) for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL)

Genmab A/S today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for subcutaneous epcoritamab (DuoBody®-CD3xCD20).

November 21, 2022
·
8 min read
Genetown

Yield10 Bioscience to Present at the CG AgriFood Tech Innovation Virtual Forum

Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the Canaccord Genuity AgriFood Tech Innovation Virtual Forum on December 1, 2022 at 1:30pm ET.

November 21, 2022
·
1 min read